PLOS is a non-profit organization on a mission to drive open science forward with measurable, meaningful change in research publishing, policy, and practice.

Building on a strong legacy of pioneering innovation, PLOS continues to be a catalyst, reimagining models to meet open science principles, removing barriers and promoting inclusion in knowledge creation and sharing, and publishing research outputs that enable everyone to learn from, reuse and build upon scientific knowledge.

We believe in a better future where science is open to all, for all.

Journals
More Content
PLOS BLOGS Speaking of Medicine and Health
Browse all PLOS Blogs
Browse all PLOS Blogs

This Week in PLoS Medicine: VBAC; cART during PHI; IPTi & more

Michael Morris General

Image Credit: Petteri Sulonen

This week wraps up the publishing month of March with our monthly editorial and three other new articles.

The PLoS Medicine Editors discuss new research studies on the risks associated with mode of childbirth following caesarean section.

In a three-arm randomized trial conducted among adult patients in HIV treatment centers in The Netherlands, Marlous Grijsen and colleagues examine the effects of temporary combination antiretroviral therapy during primary HIV infection.

A three-arm randomized trial conducted by Ivo Mueller and colleagues among infants in Papua New Guinea estimates the preventive effect against malaria episodes of intermittent preventive treatment in an area where children are exposed to both falciparum and vivax malaria.

Alex London and colleagues propose new ethical frameworks for evaluating the risks associated with research in which financial or other incentives are used to promote healthy behavior.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Back to top